Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
LIGAND PHARMA (NQ: LGND)
27.47 USD  -0.48 (-1.72%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 27.84
Bid (Size) 27.47 (400)
Ask (Size) 27.48 (100)
Prev. Close 27.95
Today's Range 27.34 - 27.90
52wk Range 11.28 - 29.92
Shares Outstanding 20,234,959
Dividend Yield N/A
Featured News
More News
How corporate insiders reacted to Japan
March 22, 2011
Just when it looked like the stock market would crumble under the weight of insider selling, the insiders retreated. The ratio of their selling to their buying is now the lowest it’s been since last... Read More
category USMO , Opinion , Commentary , and 15 more.
from MarketWatch
Somaxon paces decliners in drug sector
November 19, 2010
Somaxon is the drug sector’s lead decliner in early trading Friday after it priced a public stock offering substantially below Thursday’s closing price. Read More
category Market News , DRG , Biotechnology , and 12 more.
from MarketWatch

More News
Read More
Ligand to Present at Upcoming Investor Conferences
May 23, 2013
from Business Wire News Releases
Ligand Pharmaceuticals Earnings Review: 12 Days after Announcement Shares Up 4.3% (LGND)
May 20, 2013
from Comtex SmarTrend® News Briefs
Ligand Pharmaceuticals (LGND) Agreement with Merck KGaA Unit Terminated
May 20, 2013
from StreetInsider.com News Articles
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated
May 17, 2013
from PR Newswire
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
May 14, 2013
category Health Care , Benzinga , Biotechnology , and 3 more.
from Latest Articles from Benzinga.com
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
May 14, 2013
from Business Wire News Releases
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 7c; Approves $5M Buyback
May 08, 2013
from StreetInsider.com News Articles
Ligand Announces $5M Buyback, Q1 Earnings
May 08, 2013
category Health Care , Benzinga , Biotechnology , and 3 more.
from Latest Articles from Benzinga.com
Ligand Reports First Quarter Financial Results
May 08, 2013
from Business Wire News Releases
Ligand Pharmaceuticals Bullish Moving Average Crossover Alert (LGND)
May 08, 2013
from Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
2
Random Thoughts: The Third Dip Cometh!
Todd Harrison
3
Google, Facebook, Yahoo, and Twitter: Web Giants Make Unexpected Announcements
Carol Kopp
4
Mother of All Fed Cha-Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
5
Random Thoughts: A Signal That Bears Watching
Todd Harrison